Search earnings tickers

ALNY

2026Q1BMO

Alnylam Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2026-04-30 · Fiscal end 2026-03-31 · Features as of 2026-04-29

← Earnings history

Street

Consensus EPS1.47

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.9%

IV front—

P/C full—

P/C front—

Features as of2026-04-29

Run-up

Close—

Ret 5d-3.0%

Ret 10d-9.7%

Ret 20d-9.0%

Ret 30d-6.0%

Print

Actual EPS

1.99Beat

Estimated EPS1.47

Actual revenue

1.2B

Surprise %+35.4%

Beat / missBeat

Beat streak 41

Beat streak 81

Reaction

1-day stock reaction+0.7%

Implied vs actual

Implied 2.9%Actual 2.1%

Gap reaction+2.1%

Day result+2.8%

Next-day upYes

Realized / IV0.72×

Post tape

Post 5d-4.4%

Post 10d-5.2%

Post volume2.2M

Vol ×10d1.98×

Vol ×20d2.08×

Post range9.9%